Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 587 of 6351
-
New combo therapy aims to slow advanced kidney cancer
Disease control Recruiting nowThe purpose of the study is to evaluate the progression-free survival (PFS) of casdatifan versus placebo when each is given in combination with cabozantinib in adult patients with confirmed advanced or metastatic clear cell Renal Cell Carcinoma who have experienced progression on…
Phase 3 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
AI app aims to cut heart attack deaths by getting Clot-Busting drugs to patients faster
Disease control Recruiting nowThe aim of the study is to elucidate whether guiding by a novel artificial intelligence assisted mobile application can improve the clinical outcomes of patients in whom "guide wire passing through the lesion" could not be achieved within 120 min after diagnosis of STEMI, compare…
Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:43 UTC
-
Experimental combo therapy targets multiple cancers in new trial
Disease control Recruiting nowPhase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24 patients with extracranial anatomic radiation sites. I) After lead in of 10 patients demonstrating safety of treatment,…
Phase 1/2 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Less invasive heart valve fix could rival Open-Heart surgery for tough cases
Disease control By invitation onlyTo evaluate the safety and effectiveness of the Transcatheter aortic valve and retrievable delivery system (VitaFlow Liberty®) for the treatment of severe bicuspid aortic valve (BAV) stenosis.
Sponsor: Shanghai MicroPort CardioFlow Medtech Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:14 UTC
-
Can steroids save lives in severe pneumonia? new trial aims to find out
Disease control Not yet recruitingSevere community-acquired pneumonia (sCAP) has a high mortality rate of 25-50%. Excessive host inflammatory responses contribute to poor outcomes. Corticosteroid therapy may provide benefit; however, the optimal dosage remains unclear, and it is uncertain whether all etiologies (…
Phase 2/3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated Jun 26, 2026 13:09 UTC
-
New hope for Hard-to-Treat lymphoma: drug cocktail enters human trials
Disease control Not yet recruitingDiffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma in China and worldwide. Although standard immunochemotherapy with Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine (Oncovin), and Prednisone (R-CHOP) achieves durable remis…
Phase 1/2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 26, 2026 14:55 UTC
-
Could STI testing be the key to getting more women on HIV prevention?
Prevention Recruiting nowGlobally, new HIV infections are concentrated in eastern and southern Africa where the infections are largely acquired by women outside of known key populations. Identifying African women at high risk for HIV acquisition and successfully engaging them in HIV prevention services, …
Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jun 26, 2026 16:59 UTC
-
New 'Two-Pronged' CAR-T attack shows promise for tough blood cancers
Disease control Recruiting nowThis is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability, preliminary efficacy and immunogenicity of OriV508 injection for patients with relapsed/refractory hematological malignancies.
Early phase 1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope for Tough-to-Treat blood cancers: phase 3 trial launches
Disease control Recruiting nowThis is a phase 3, open-label, randomized, multi-center study assessing the efficacy and safety of DZD8586 versus investigator's choice in participants with chronic lymphocytic leukemia/small lymphocytic lymphoma who have progressed following prior therapy. Primary objective of …
Phase 3 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could steroids slash death rates from a rare pneumonia?
Disease control Not yet recruitingPneumocystis jirovecii pneumonia (PJP) is one of the common severe complications in immunocompromised patients, with a reported mortality rate of 60-80%. Reducing mortality from PJP is crucial for improving outcomes in critically ill non-HIV immunocompromised patients and allevia…
Phase 3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated Jun 26, 2026 14:24 UTC
-
Drones vs. ambulances: can flying defibrillators save rural hearts?
Knowledge-focused Recruiting nowThe overall goal of this project is to design, develop, and pilot test an emergency healthcare drone delivery system suitable for rural communities that can deliver AEDs to out-of-hospital cardiac arrest (OHCA) locations more rapidly than can be achieved with current first respon…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New study tests less invasive surgery for severe brain bleeds
Disease control Recruiting nowThis observational cohort study evaluates the safety and effectiveness of minimally invasive surgery (MIS) compared with standard medical management in adults with spontaneous deep intracerebral hemorrhage. Consecutive patients admitted to People's Hospital 115 and Tam Anh Genera…
Sponsor: Huynh Quoc Huy • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New combo aims to wipe out breast cancer before surgery
Disease control Recruiting nowThe goal of this clinical trial is to learn if QL1706 is effective in early HR+/HER2- breast cancer. It will also learn about the safety of QL1706. The main questions it aims to answer are: Does QL1706 combined with neoadjuvant chemotherapy improve the pCR rate of early HR+/HER2…
Phase 2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New combo therapy gives hope to elderly esophageal cancer patients
Disease control Recruiting nowThis study was conducted in elderly (≥70 years old) patients with locally advanced esophageal squamous cell carcinoma (ESCC). Aim to evaluate the efficacy and safety of Iparomlimab consolidation therapy following concurrent chemoradiation with S-1 in elderly patients with unresec…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for lymphoma patients: drug targets cancer without chemo
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and effectiveness of treating previously untreated Follicular Lymphoma (FL) with odronextamab. The name of the study drug in this research study is: -Odronextamab (a type of monoclonal antibody)
Phase 2 • Sponsor: Gottfried von Keudell, MD PhD • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New Same-Day test could transform cervical cancer screening in Low-Resource areas
Diagnosis Recruiting nowThis study evaluates the diagnostic accuracy and feasibility of a same-day cervical cancer screening strategy using HPV self-sampling followed by digital telecytology triage among HPV-positive women in Cameroon. Women aged 30-49 years (or 25-49 years if HIV-positive) will undergo…
Sponsor: University Hospital, Geneva • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Cell therapy combo aims to boost kidney cancer treatment
Disease control Recruiting nowThis is a multicenter, randomized, open-label, active-controlled Phase II clinical study evaluating the efficacy and safety of IBR854 combined with Pazopanib versus Pazopanib in Advanced Renal Cell Carcinoma.
Phase 2 • Sponsor: Imbioray (Hangzhou) Biomedicine Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Which therapy restores walking after stroke? a Head-to-Head test
Disease control Recruiting nowAs neurodevelopmental technique and mirror therapy had different effects on lower limb coordination, functions and ambulation. Both had proven to be helpful in the stroke patients to gain functional independency. Therefore, there was need to find out the best treatment approach e…
Sponsor: University of Lahore • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a targeted nerve block tame Post-Surgery pain and curb opioid use?
Symptom relief Recruiting nowThe goal of this clinical trial is to find out whether a Pericapsular Nerve Group (PENG) block, a type of nerve block used to control pain, can reduce pain after surgery in adults with an acetabular (hip socket) fracture who are undergoing surgical repair. The study will also eva…
Sponsor: University of Puerto Rico • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Virtual reality may soothe Stroke-Related agitation
Symptom relief CompletedThis randomized controlled, single-blind study evaluates the effect of a Virtual Reality (VR) application on agitation levels and physiological vital signs in patients with acute stroke. Participants are randomly assigned to an intervention group receiving standard clinical care …
Sponsor: Ankara Etlik City Hospital • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC